24 Nov, 2021
On November 23, 2021, Genor Biopharma received the Outstanding Employer of the Year 2021 award from Liepin.
21 Nov, 2021
The first Chinese Lymphoma Patients Conference was held on the occasion of the 10th anniversary of the creation of Lymphoma patients and their families, as well as medical experts focusing on the treatment of lymphoma disease, and a number of pharmaceutical companies, including Genor Biopharma, were invited to participate in the comprehensive communication platform.
15 Nov, 2021
HNHE China 2021 was held in Hainan province from November 12-14. Dr. HAN Shuhua, Chief Scientific Officer, and Mr. CHEN Wende, Chief Operating Officer, of Genor Biopharma were invited to attend the conference and deliver speeches at the forums.
02 Nov, 2021
Dr. GUO Feng, existing Executive Director and Chief Executive Officer, Genor Biopharma, has been appointed Chairman of the company. Meanwhile, the Board further announced that Dr. LYU Dong, currently the managing director of Zhuhai Gao Ling Equity Investment Management Co., Ltd. is appointed as a non-executive Director of Genor Biopharma.
28 Oct, 2021
The Asia Biopharma Industry Innovation Summit 2021, hosted by Taas Labs, kicked off in Shanghai on October 28. Dr. Joe ZHOU, Founder & President of Genor Biopharma, delivered an opening speech with the theme of "Current Status and Trends of Antibody Drug Development: BsAb." He shared his views on the changes in the biopharmaceutical industry, the current status of China's drug regulatory environment, and the opportunities and challenges in the development of biologic drugs. He also introduced the progress of Genor Biopharma bispecific/multi-specific antibodies.